ConductScience.org, home

Paper36009355

Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis.

Jezernik G and 2 others. Biomedicines, 2022. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. Papers, record 36009355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36009355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis.
PubMed
Journal
Biomedicines
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2022-08-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jezernik GGregorhttps://orcid.org/0000-0003-1110-5345
2Gorenjak MMariohttps://orcid.org/0000-0003-4208-9683
3Potočnik UUrošhttps://orcid.org/0000-0003-1624-9428

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P3-0067Slovenian Research AgencyPubMed
J3-9258Slovenian Research AgencyPubMed

Source PubMed

Download CSV of grants

References154

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125292482IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor α inhibitors in rheumatoid arthritis.Int J Rheum Dis2014https://conductscience.org/library/papers/25292482PubMed
220444755Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.Ann Rheum Dis2010https://conductscience.org/library/papers/20444755PubMed
317967830B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.Ann Rheum Dis2008https://conductscience.org/library/papers/17967830PubMed
419327235The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients.Clin Exp Rheumatol2009https://conductscience.org/library/papers/19327235PubMed
533691749Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment.Arthritis Res Ther2021https://conductscience.org/library/papers/33691749PubMed
616855168Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.Ann N Y Acad Sci2006https://conductscience.org/library/papers/16855168PubMed
721801431Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.Arthritis Res Ther2011https://conductscience.org/library/papers/21801431PubMed
834796837Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.Clin Exp Rheumatol2022https://conductscience.org/library/papers/34796837PubMed
925546405Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.PLoS One2014https://conductscience.org/library/papers/25546405PubMed
1024253594Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome.Pharmacogenet Genomics2014https://conductscience.org/library/papers/24253594PubMed
1116720636The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.Rheumatology (Oxford)2007https://conductscience.org/library/papers/16720636PubMed
1222550316Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.Ann Rheum Dis2012https://conductscience.org/library/papers/22550316PubMed
1319262425Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients.Pharmacogenet Genomics2009https://conductscience.org/library/papers/19262425PubMed
1420032971CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis.Clin Pharmacol Ther2010https://conductscience.org/library/papers/20032971PubMed
1526526676Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis.Clin Rheumatol2015https://conductscience.org/library/papers/26526676PubMed
1624728031Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis.Rheumatol Int2014https://conductscience.org/library/papers/24728031PubMed
1728010726Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis.Arthritis Res Ther2016https://conductscience.org/library/papers/28010726PubMed
1828112584Association of Fcgamma receptor type 2A and 3A genotypes with rheumatoid arthritis in Chinese population.Pharmacogenomics2017https://conductscience.org/library/papers/28112584PubMed
1927532898Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.Mol Med2016https://conductscience.org/library/papers/27532898PubMed
2018930989
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
Ann Rheum Dis2009https://conductscience.org/library/papers/18930989PubMed

See all 154 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39337694Discovery of Novel Biomarkers with Extended Non-Coding RNA Interactor Networks from Genetic and Protein Biomarkers.Int J Mol Sci2024https://conductscience.org/library/papers/39337694PubMed
37631238Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis.Pharmaceutics2023https://conductscience.org/library/papers/37631238PubMed

Download CSV of cited by

Genes290

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AADAT51166PubTator's text mininghttps://conductscience.org/library/genes/51166NCBI Gene
ABI3BP25890PubTator's text mininghttps://conductscience.org/library/genes/25890NCBI Gene
ADAM128038PubTator's text mininghttps://conductscience.org/library/genes/8038NCBI Gene
ADAMTS19510PubTator's text mininghttps://conductscience.org/library/genes/9510NCBI Gene
ADAMTS511096PubTator's text mininghttps://conductscience.org/library/genes/11096NCBI Gene
ADAMTSL29719PubTator's text mininghttps://conductscience.org/library/genes/9719NCBI Gene
ADI155256PubTator's text mininghttps://conductscience.org/library/genes/55256NCBI Gene
ADM133PubTator's text mininghttps://conductscience.org/library/genes/133NCBI Gene
AGPAT456895PubTator's text mininghttps://conductscience.org/library/genes/56895NCBI Gene
AKAP910142PubTator's text mininghttps://conductscience.org/library/genes/10142NCBI Gene
ANAPC1151529PubTator's text mininghttps://conductscience.org/library/genes/51529NCBI Gene
AP1S28905PubTator's text mininghttps://conductscience.org/library/genes/8905NCBI Gene
APMAP57136PubTator's text mininghttps://conductscience.org/library/genes/57136NCBI Gene
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
APOA2336PubTator's text mininghttps://conductscience.org/library/genes/336NCBI Gene
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene
APOC1341PubTator's text mininghttps://conductscience.org/library/genes/341NCBI Gene
APOC3345PubTator's text mininghttps://conductscience.org/library/genes/345NCBI Gene
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APOM55937PubTator's text mininghttps://conductscience.org/library/genes/55937NCBI Gene

See all 290 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36009355

GET https://conductscience.org/api/papers/v1/36009355/references?page=2